<SEC-DOCUMENT>0001213900-14-009139-index.html : 20141229 <SEC-HEADER>0001213900-14-009139.hdr.sgml : 20141225 <ACCEPTANCE-DATETIME>20141229061853 ACCESSION NUMBER: 0001213900-14-009139 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20141229 DATE AS OF CHANGE: 20141229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-184762 FILM NUMBER: 141310623 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>424B3 <SEQUENCE>1 <FILENAME>f424b3122414max_soligenix.htm <DESCRIPTION>PROSPECTUS FILED PURSUANT TO RULE 424(B)(3) <TEXT> Document 1 - file: f424b3122414max_soligenix.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>soligenix.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: soligenix.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: image_001.jpg
</DOCUMENT> </SEC-DOCUMENT>